semaglutide heart failure trial π Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality vs sitagliptin, but tirzepatide offered no Analysis of the SELECT trial
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 9 - Oct 14













.jpg)







.jpg?sfvrsn=f85d055_0)






